| PERIOD ENDING | 31-Dec-08 | | Total Revenue | 153,024 | | Cost of Revenue | 43,201 | | | Gross Profit | 109,823 | | | Operating Expenses | | Research Development |
-
| | Selling General and Administrative | 5,738 | | Non Recurring |
-
| | Others | 7,624 | | | | Total Operating Expenses |
-
| | | | Operating Income or Loss | 96,461 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| | Earnings Before Interest And Taxes | 96,461 | | Interest Expense | 621 | | Income Before Tax | 95,840 | | Income Tax Expense | 1,060 | | Minority Interest |
-
| | | | Net Income From Continuing Ops | 94,780 | | | Non-recurring Events | | Discontinued Operations |
-
| | Extraordinary Items |
-
| | Effect Of Accounting Changes |
-
| | Other Items |
-
| | | | Net Income | 94,780 | | Preferred Stock And Other Adjustments |
-
| | | Net Income Applicable To Common Shares | $94,780 |
|
0.96% Nasdaq 
Income Statement
